Table 2. Clinical Course.
| First hospital admission | Second hospital admission | Third hospital admission | After discharge | |
|---|---|---|---|---|
| PR3-ANCA | (+) | (+) | (+) | (-) |
| < 3.5 (U/mL) | 56.7 | 14.7 | 31.4 | 1.9 |
| MPO-ANCA | (-) | (+) | (+) | (+) |
| < 3.5 (U/mL) | 1 | 125.4 | 140 | 26.4 |
| Eosinophils | (-) | (-) | (+) | (-) |
| < 1,000 (cells/µL) | 563 | 436 | 5,635 | 0 |
| Diagnosis | Bacterial pneumonia | Heart failure | EGPA, bacterial pneumonia | EGPA |
| Chest CT | GGO | GGO, infiltration, pleural effusion | GGO, infiltration, pleural effusion | GGO |
| Treatment | Antibiotics | Diuretics | Corticosteroids, antibiotics | Mepolizumab |
CT: computed tomography; EGPA: eosinophilic granulomatosis with polyangiitis; GGO: ground-glass opacities; MPO-ANCA: myeloperoxidase antineutrophil cytoplasmic antibody; PR3: proteinase 3 antineutrophil cytoplasmic antibody.